Bright Minds Biosciences Logo

Bright Minds Biosciences

🇺🇸
DRUG
CA10919W4056

Bright Minds Biosciences is a US-based biotech company specializing in the development of innovative therapeutics to treat neurological and psychiatric disorders. The company focuses on novel drug candidates that precisely target serotonin receptors to advance treatments for mental health conditions.

Next Quarterly Earnings

Thursday, December 17, 2026
CW 51
After-Hours
In 65 days

After-hours — typically from around 10:00 p.m. German time (after the US close at 4:00 p.m. New York time).

Quiet period starts on November 19, 2026

Stock Price

Frequently asked questions

When will Bright Minds Biosciences report its next quarterly earnings?

Bright Minds Biosciences is scheduled to report its next quarterly earnings on 12/17/2026. After-hours — typically from around 10:00 p.m. German time (after the US close at 4:00 p.m. New York time).

When did Bright Minds Biosciences last report quarterly earnings?

Bright Minds Biosciences last reported quarterly earnings on 8/14/2026 (Q2 2026). Earnings per share (EPS) came in at -0.17 USD.

How often has Bright Minds Biosciences beaten expectations?

Bright Minds Biosciences has beaten analyst EPS estimates in 5 of its last 5 evaluated quarters (beat rate: 100%).

How do I add the Bright Minds Biosciences earnings dates to my calendar?

Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.

All Dates

Q3 2026
Estimate:-$1.12
Actual:—
Q2 2026
Beat
Estimate:-$1.28
Actual:-$0.17
Difference:+$1.11
Price reaction (1 day):+4.0 %
Price reaction (7 days):+1.3 %
Q1 2026
Beat
Estimate:-$0.88
Actual:-$0.79
Difference:+$0.08
Price reaction (1 day):+11.1 %
Price reaction (7 days):+15.8 %
Q3 2025
Beat
Estimate:-$1.19
Actual:-$0.97
Difference:+$0.22
Q2 2025
Beat
Estimate:-$1.00
Actual:-$0.58
Difference:+$0.42
Q1 2025
Beat
Estimate:-$0.88
Actual:-$0.74
Difference:+$0.14

Earnings statistics

Estimates vs. results

5/5
Quarters above estimates
100%
Beat rate
+19.4%
Avg. EPS surprise

Basis: 5 quarters with an analyst estimate and reported EPS.

Past price reactions are not a reliable indicator of future performance.

Company Information

Name
Bright Minds Biosciences
Ticker Symbol
DRUG
ISIN
CA10919W4056
Country
🇺🇸
USA
Sector